Deleted No
Hibernated No
Last Checked Oct. 8, 2021

Created

Sat Oct 02 00:20:31 +0000 2021

Likes

10

Retweets

2

Source

Twitter for iPhone

View Raw Data

JSON Data

View on Twitter

Likely Available
Profile Image

Lisa Boothe ๐Ÿ‡บ๐Ÿ‡ธ @LisaMarieBoothe

@DebunkJunction @BMeiselas Because Merck doesnโ€™t have a patent on ivermectin and it is incredibly cheap to make. However, Merck has a $1.2 billion contact with the U.S. government for this new therapeutic which costs $700 per patient. https://t.co/oxOHtwpl83 — PolitiTweet.org

Posted Oct. 2, 2021